A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass
1 other identifier
observational
11
1 country
1
Brief Summary
Improvements in imaging technology have allowed for the development of small endoscopes ("slim scopes") half the size of a typical endoscope. These small endoscopes can be passed transnasally into the esophagus and stomach with only local anesthesia to the nasal passage without the need for deep sedation. They have been used in the detection of diseases of the esophagus and stomach,3,4 but have not been used in the detection of complications in the post bariatric population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 17, 2012
CompletedFirst Posted
Study publicly available on registry
February 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 7, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2014
CompletedNovember 7, 2017
April 1, 2017
2.8 years
January 17, 2012
November 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anastomotic ulcer and diameter
Presence of anastomic ulcer seen by slim scope
1 year
Secondary Outcomes (1)
Presence of anastomotic stricture and diameter
1 years
Study Arms (1)
Patients who have undergone RYGB
Patients who have undergone RYGB and have been referred for an EGD
Interventions
Transoral endoscopy versus transoral endoscopy
Eligibility Criteria
This pilot study will attempt to recruit 20 subjects over one year.
You may qualify if:
- Subjects must be able to review and sign informed consent
- Subjects have undergone Roux en Y gastric bypass
- Subjects report any of the following symptoms that would prompt investigation and referral for an upper endoscopy; abdominal pain, nausea, vomiting or problems swallowing
You may not qualify if:
- Patients who cannot give and sign informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John O Evans, MD
Wake Forest University Baptist Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2012
First Posted
February 6, 2012
Study Start
September 1, 2011
Primary Completion
July 7, 2014
Study Completion
July 7, 2014
Last Updated
November 7, 2017
Record last verified: 2017-04